Search results | cancer

Reports

Cancer Symptoms Partnering

The Cancer Symptoms Partnering report provides understanding and access to the cancer symptoms partnering deals and agreements entered into by the worlds leading healthcare companies.

Cancer Diagnostics Partnering Terms and Agreements

The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in cancer diagnostics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer diagnostics partnering contract documents Top cancer diagnostics deals by value   The more »

Cancer Monoclonal Antibody Partnering Terms and Agreements

The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies

Cancer Vaccine Partnering Agreements

The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies

Bladder Cancer Partnering

The Bladder Cancer Partnering provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies

Brain Cancer Partnering

The Brain Cancer Partnering provides understanding and access to the brain cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

Breast Cancer Partnering

The Breast Cancer Partnering provides understanding and access to the breast cancer partnering deals and agreements entered into by the worlds leading healthcare companies

Cervical Cancer Partnering

The Cervical Cancer Partnering provides understanding and access to the cervical cancer partnering deals and agreements entered into by the worlds leading healthcare companies

Colorectal Cancer Partnering

The Colorectal Cancer Partnering provides understanding and access to the colorectal cancer partnering deals and agreements entered into by the worlds leading healthcare companies

Gastric Cancer Partnering

The Gastric Cancer Partnering provides understanding and access to the gastric cancer partnering deals and agreements entered into by the worlds leading healthcare companies

Insights

Industry analysis: Cancer monoclonal antibody partnering on the rise

Monoclonal antibodies are developed to be very selective in targeting cells. This is why they have come to be an indispensable research tool in cancer treatment being able to specifically target tumor cells.

Trends analysis: Cancer vaccine partnering on the rise

Recent trends analysis suggests that research in personalized medicine and vaccine development for disease treatment has increased partnering and collaboration in this arena.

Cancer vaccine

A cancer vaccine is a vaccine that treats existing cancer or prevents the development…

Novartis loses India Glivec cancer drug patent case

A recent ruling in India raises questions for big pharma in emerging markets where a battle is underway between expensive branded medicines and cheap generic drugs

Teva, a top pharma company halts tests of cancer drug biosimilar

Teva Pharmaceutical Industries, a top pharma establishments has suspended testing of its generic version of Rituxan, a $7-billion a year drug, at the third stage of clinical trials

VentiRx Pharma inks pharma partnering deal with Celgene for cancer drug VTX-2337

VentiRx Pharmaceuticals announced the formation of an exclusive, world-wide pharma partnering collaboration with Celgene Corporation for the development of VTX-2337, a highly potent and selective TLR8 agonist for the treatment of cancer.

Valeant Pharma partners with the American Breast Cancer Foundation

Kinerase, a sub-brand ofValeant Pharmaceuticals North America, is pleased to announce their pharma partners agreement with the American Breast Cancer Foundation for the month of October

Bio News: Cosmo Pharma talking sale of its cancer detection dye by 2013

Cosmo Pharmaceuticals SpA (COPN), makes bio news with the potential sale of its dye which may help detect pre-cancerous colon growths

4SC seeks three potential pharma partners for cancer drug

4SC AG (VSC) said it’s in talks with at least three potential pharma partners after patients in a mid-stage clinical trial of its liver cancer drug Resminostat combined with Bayer AG (BAYN)’s Nexavar survived for eight months.

Sanofi seeking pharma partners in India for cancer & diabetes drug discovery

The world’s fourth largest drug-maker, Sanofi, will tap Indian talent for its drug discovery in the field of oncology and diabetes and is looking for pharma partners to execute the same.

Events

Collaborative R&D for prostate cancer prognostic test

Definiens and Metamark Genetics announced a multi-year agreement covering use of the Definiens image analysis solution for the ProMark.

Deals

Merck and Syndax partner for cancer combo clinical

Syndax and Merck have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining entinostat, an investigational epigenetic therapy, with KEYTRUDA

Merck Serono and Intrexon in CAR-T cancer pact

Intrexon and Merck Serono announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies

Eli Lilly and Innovent in pact for three cancer treatments

Eli Lilly and Innovent Biologics announced one of the largest biotech drug development collaborations in China to date between a multi-national and domestic company

BMS and Rigel ink cancer immunotherapies pact

Rigel Pharmaceuticals and Bristol-Myers Squibb have entered into a collaboration agreement for the discovery, development and commercialization of cancer immunotherapies

Teva enters into pharma licensing deal with Eagle Pharmaceuticals for cancer drug

Teva Pharmaceutical Industries has entered into a $120 million pharma licensing agreement that will allow it to distribute and promote a competitor to its own cancer drug, Eagle Pharmaceuticals EP-3102.

Boehringer Ingelheim and Vanderbilt partner for RAS inhibitors for cancer

Boehringer Ingelheim has established a research alliance with Vanderbilt University and the cancer drug discovery laboratory

AstraZeneca partners with Molplex for mechanisms of cancer progression

Molplex Pharmaceuticals has announced a pioneering new research collaboration agreement with AstraZeneca

Roche and Foundation Medicine in personalized meds for cancer pact

Foundation Medicine and Roche enter into a broad strategic collaboration to further advance Foundation Medicine’s market-leading position in molecular information and genomic analysis

Vaccinex and Janssen in cancer collaboration

Vaccinex has entered into a research collaboration with Janssen Research & Developmentfor the creation of novel anti-cancer agents

GSK and Clovis in lung cancer pact

Clovis Oncology have entered into a clinical trial collaboration with GlaxoSmithKline to evaluate a novel combination therapy targeting mutant epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC)